Question

Why does the body reject transplanted organs?

Vault Verified
Curated Intelligence
Definitive Source
Answer

Because the immune system is designed to identify and destroy anything not recognised as self, and a donated organ is genetically foreign tissue.

How the immune system tells self from non-self. Nearly every cell displays surface proteins called HLA (human leukocyte antigen) molecules — the human version of the major histocompatibility complex. These act as an identity badge, and they are extraordinarily variable between individuals. Your immune system learns your own HLA pattern during development and treats anything different as foreign.

A transplanted organ carries the donor's HLA. T cells recognise it as non-self and attack.

The types of rejection:

Hyperacute — within minutes to hours, caused by pre-existing antibodies, usually from blood group incompatibility. The organ fails immediately. Crossmatching before surgery exists to prevent it, and it is now rare.

Acute — days to months, T-cell mediated. Common, often treatable if caught early with increased immunosuppression, which is why post-transplant monitoring is intensive.

Chronic — months to years. Gradual fibrosis and vascular narrowing. Poorly understood, difficult to treat, and the main reason transplanted organs have finite lifespans.

How rejection is managed:

Tissue matching. The closer the HLA match, the lower the risk — which is why related donors are often preferable and why matching registries exist.

Lifelong immunosuppression, the central trade-off in transplantation. Suppressing the immune system prevents rejection and simultaneously increases susceptibility to infection and certain cancers. Getting the balance right is the ongoing clinical challenge, and the drugs carry substantial side effects.

Why some tissues are different. The cornea can often be transplanted without matching or systemic immunosuppression, because it has no blood supply — an immune-privileged site the immune system does not patrol normally.

Graft-versus-host disease is the reverse problem, occurring in bone marrow transplants where donor immune cells attack the recipient.

Related Questions